Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immunovant Q2 EPS $(0.41) Down From $(0.35) YoY

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.
byBenzinga Newsdesk
November 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts